General Actions (Not specific medical benefits for the user)
| Core Action | Mechanism |
| Lowers Blood Glucose | Empagliflozin selectively and reversibly inhibits the Sodium-Glucose Co-Transporter 2 (SGLT2) in the renal tubules, leading to increased urinary glucose excretion, thus lowering blood sugar. |
| Protects the Heart | Independently of its glucose-lowering effects, it has been shown to significantly reduce the risk of cardiovascular death and hospitalization for heart failure in high-risk patients. |
| Supports Kidney Health | Helps slow the progression of chronic kidney disease (nephropathy) in patients with Type 2 diabetes by reducing pressure within the kidney filters. |
| Promotes Modest Weight Loss | The loss of glucose and associated calories through the urine often leads to modest, beneficial weight loss and a reduction in blood pressure. |
⚠️ Important Safety Note:
Empaglif 10mg Tablet is a prescription medication.
Warning! You must be logged in to submit a review.
Login
Customer questions & answers
Customer reviews
0 out of 5